First Time Loading...

Oncolytics Biotech Inc
TSX:ONC

Watchlist Manager
Oncolytics Biotech Inc Logo
Oncolytics Biotech Inc
TSX:ONC
Watchlist
Price: 1.61 CAD -0.62% Market Closed
Updated: May 8, 2024

Oncolytics Biotech Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncolytics Biotech Inc
Cash from Operating Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Oncolytics Biotech Inc
TSX:ONC
Cash from Operating Activities
-CA$28.4m
CAGR 3-Years
-9%
CAGR 5-Years
-19%
CAGR 10-Years
-2%
Zymeworks Inc
NYSE:ZYME
Cash from Operating Activities
-$118.3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Operating Activities
-$81.8m
CAGR 3-Years
-40%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$20.4m
CAGR 3-Years
41%
CAGR 5-Years
17%
CAGR 10-Years
-8%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$10.7m
CAGR 3-Years
-222%
CAGR 5-Years
-35%
CAGR 10-Years
-2%

See Also

What is Oncolytics Biotech Inc's Cash from Operating Activities?
Cash from Operating Activities
-28.4m CAD

Based on the financial report for Dec 31, 2023, Oncolytics Biotech Inc's Cash from Operating Activities amounts to -28.4m CAD.

What is Oncolytics Biotech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-2%

Over the last year, the Cash from Operating Activities growth was -22%. The average annual Cash from Operating Activities growth rates for Oncolytics Biotech Inc have been -9% over the past three years , -19% over the past five years , and -2% over the past ten years .